Optimising homeostasis

British Medical Bulletin

Volumn 56, Issue 2, 2000, Pages 422-435

  Bath, Philip M W ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN EDEMA; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTHERMIA; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; STROKE;

EID: 0033788098     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1258/0007142001903067     Document Type: Review

References (119)

1. Complications of acute stroke
2. Blood pressure after stroke
3. Blood pressure course in patients with acute stroke and matched controls
4. Blood pressure after stroke. A one-year follow-up study
5. Blood pressure during the first minutes of focal cerebral ischemia
6. Pathophysiology and management of hypertension in acute ischemic stroke
7. Blood pressure changes in acute cerebral infarction and hemorrhage
8. Factors influencing admission blood pressure levels in patients with acute stroke
9. Factors affecting changes in blood pressure after acute stroke
10. Prognostic value of the stress response following stroke
11. Stress hormone and blood glucose response following acute stroke in the elderly
12. Serum cortisol and outcome of ischemic brain infarction
13. Pattern of activation of the hypothalamic-pituitary-adrenal axis in acute stroke
14. Cardiac output in patients with acute stroke
15. The natural history of cerebrovascular disease
16. Predictors of long term recovery in cerebrovascular disease
17. The natural history of acute cerebrovascular disease: A retrospective study of 769 patients
18. The prognostic value of admission blood pressure in patients with acute stroke
19. The predictive role of 24-hour compared to casual blood pressure levels on outcome following acute stroke
20. Prospects for patients with strokes, with special reference to the hypertensive hemiplegic
21. The outlook in hemiplegia
22. What is the correct management of blood pressure in acute stroke? The Blood pressure in Acute Stroke Collaboration
23. Autoregulation of brain circulation in severe arterial hypertension
24. Impaired neurogenic cerebrovascular control and dysautoregulation after stroke
25. The treatment of brain ischaemia with vasopressor drug
26. Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety
27. Hypertension in acute ischaemic strokes-treat
28. Relation between blood pressure and outcome in intracerebral haemorrhage
29. Blood pressure and functional recovery in acute ischemic stroke
30. The National Institute of Neurological disorders and stroke rt-PA, Stroke Study Group. Tissue plasminogen activator for acute stroke
31. Hypertension and its treatment in the NINDS rt-PA stroke trial
32. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)
33. Management of hypertension in patients with acute stroke
34. Intravenous nimodipine in acute stroke: Interim analysis of randomized trials [abstract]
35. Intravenous Nimodipine West European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke
36. A randomised, double-blind, placebo-controlled trial of nimodipine in acute ischemic hemispheric stroke
37. The effects of lifarizine in acute cerebral infarction: A pilot study
38. Should hypertension be treated after acute stroke? A randomised controlled trial using single photon emission computed tomography
39. Hypertension in acute ischaemic strokes - Not to treat
40. Hypertension in acute ischaemic strokes
41. Acute hypertension after stroke: The scientific basis for treatment decisions
42. Treating hypertension after stroke
43. European strategies for early intervention in stroke
44. Stroke and hypertension. Antihypertensive therapy withdrawal
45. Hypertension and stroke - Rationale behind the ACCESS trial
46. Perindopril reduces blood pressure but not cerebral blood flow in patients with recent cerebral ischemic stroke
47. Low dose beta blockade in acute stroke ('BEST' trial): An evaluation
48. Pathophysiological assessment of nitric oxide (given as sodium nitroprusside) in acute ischaemic stroke
49. The effect of nitric oxide, given as transdermal glyceryl trinitrate, on blood pressure and platelet function in acute stroke
50. Safety, tolerability, and pharmacokinetics of the N-methyl-D-aspartate antagonist Dextrorphan in patients with acute stroke
51. Blood pressure lowering in patients with cerebrovascular disease: Results of the PROGRESS (perindopril protection against recurrent stroke study) pilot phase
52. Reactive hyperglycaemia in patients with acute stroke
53. The prognostic value of stress hyperglycaemia and previously unrecognized diabetes in acute stroke
54. Increasing age, diabetes mellitus and recovery from stroke
55. The influence of hyperglycemia and diabetes mellitus on immediate and 3-month morbidity and mortality after acute stroke
56. Does hyperglycaemia play a role on the outcome of acute ischaemic stroke patients?
57. Hyperglycemia in the acute phase of stroke is not caused by stress
58. Stroke in patients with diabetes
59. Is hyperglycaemia and independent predictor of poor outcome after acute stroke? Results of a long term follow up study
60. Prevalence of admission hyperglycaemia across clinical subtypes of acute stroke
61. Clinical restitution following cerebral ischemia in hypo-, normo- and hyperglycemic rats
62. Hyperglycemia enlarges infarct size in cerebrovascular occlusion in cats
63. Focal ischemia of the rat brain, with special reference to the influence of plasma glucose concentration
64. Progressing cerebral infarction in relation to plasma glucose in gerbils
65. Hyperglycemia reduces the extent of cerebral infarction in rats
66. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus
67. Prognosis after stroke in diabetic patients. A controlled prospective study
68. The influence of hyperglycemia on outcome of cerebral infarction
69. Hyperglycaemia and mortality from acute stroke
70. Acid-base changes during complete brain ischemia
71. Fatal strokes in hyperglycemic cats
72. Hemorrhagic infarction: Risk factors, clinical and tomographic features, and outcome
73. Hyperglycemia and hemorrhagic transformation of cerebral infarcts
74. Moderate hyperglycaemia worsens acute blood-brain barrier injury after forebrain ischemia in rats
75. Cerebrovascular reactivity by transcranial Doppler ultrasonography in insulin dependent diabetic patients
76. Insulin protects cognitive function in experimental stroke
77. Intraventricular administration of insulin and IGF-1 in transient forebrain ischemia
78. Insulin reduction of cerebral infarction due to transient focal ischemia
79. Glucose and insulin therapy in acute stroke; why delay further?
80. Randomised trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year
81. Metabolic modulation of acute myocardial infarction. The ECLA glucose-insulin-potassium pilot trial
82. Glucose-insulin-potassium for acute myocardial infarction. Remarkable results from a new prospective, randomized trial
83. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia
84. Mortality and morbidity of acute cerebral infarction related to temperature and basal analytic parameters
85. Fever in acute stroke worsens prognosis
86. Body temperature in acute stroke: Relation to stroke severity, infarct size, mortality, and outcome
87. Timing for fever-related brain damage in acute ischemic stroke
88. Delayed postischemic hyperthermia in awake rats worsens the histopathological outcome of transient focal cerebral ischemia
89. Body temperature and fibrinogen are related to early neurological deterioration in acute ischemic stroke
90. Therapeutic modulation of brain temperature: Relevance to ischemic brain injury
91. Hypothermia as a potential treatment for cerebral ischemia
92. Effects of hypothermia on the rate of excitatory amino acid release after ischemic depolarization
93. Mild hypothermic intervention after graded ischemic stress in rats
94. Reduction by delayed hypothermia of cerebral infarction following middle cerebral artery occlusion in the rat: A time-course study
95. Mild hypothermia reduces infarct size resulting from temporary but not permanent focal ischemia in rats
96. Postischemic (1 hour) hypothermia significantly reduces ischemic cell damage in rats subjected to 2 hours of middle cerebral artery occlusion
97. A phase II study of moderate hypothermia in severe brain injury
98. Treatment of traumatic brain injury with moderate hypothermia
99. Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction
100. Brain edema after stroke
101. 'Malignant' middle cerebral artery territory infarction
102. Decompressive craniectomy for cerebral infarction. An experimental study in rats
103. Hemicraniectomy for acute massive cerebral infarction
104. Treatment of right hemispheric cerebral infarction by hemicraniectomy
105. Decompressive surgery in space-occupying hemispheric infarction: Results of an open, prospective trial
106. Thrombolysis reduces the volume of ischemic lesions in humans
107. Cerebellar hemorrhage and infarction
108. Cerebellar infarcts in the area of supply of the PICA and their surgical treatment
109. German-Austrian scape occupying cerebellar infarction study (GASCIS): Study design, methods, patient characteristics
110. Therapeutic strategies in space-occupying cerebellar infarction based on clinical, neuroradiological and neurophysiological data
111. Neurosurgical management of cerebellar haematoma and infarct